Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

NCT06160271 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: PET scan of 68Ga-FAPI

Sponsor

Central Hospital, Nancy, France